• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2014 ESC/EACTS guidelines on myocardial revascularization.

作者信息

Windecker Stephan, Kolh Philippe, Alfonso Fernando, Collet Jean-Philippe, Cremer Jochen, Falk Volkmar, Filippatos Gerasimos, Hamm Christian, Head Stuart J, Jüni Peter, Kappetein A Pieter, Kastrati Adnan, Knuuti Juhani, Landmesser Ulf, Laufer Günther, Neumann Franz-Josef, Richter Dimitrios J, Schauerte Patrick, Sousa Uva Miguel, Stefanini Giulio G, Taggart David Paul, Torracca Lucia, Valgimigli Marco, Wijns William, Witkowski Adam

机构信息

Cardiology, Bern University Hospital, Freiburgstrasse 4, CH-3010 Bern, Switzerland.

出版信息

EuroIntervention. 2015 Jan;10(9):1024-94. doi: 10.4244/EIJY14M09_01.

DOI:10.4244/EIJY14M09_01
PMID:25187201
Abstract
摘要

相似文献

1
2014 ESC/EACTS guidelines on myocardial revascularization.2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
EuroIntervention. 2015 Jan;10(9):1024-94. doi: 10.4244/EIJY14M09_01.
2
Implications of new ESC/EACTS guidelines on myocardial revascularization for patients with multivessel coronary artery disease.欧洲心脏病学会/欧洲心胸外科学会关于多支冠状动脉疾病患者心肌血运重建的新指南的影响
Interact Cardiovasc Thorac Surg. 2011 May;12(5):663-6. doi: 10.1510/icvts.2010.261024.
3
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
EuroIntervention. 2019 Feb 20;14(14):1435-1534. doi: 10.4244/EIJY19M01_01.
4
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组编写，欧洲经皮心血管介入协会（EAPCI）提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
5
The new 2011 ACCF/AHA Guidelines on Coronary Artery Bypass Grafting surgery: are they different from the 2010 ESC/EACTS Guidelines on Myocardial Revascularisation?2011年美国心脏病学会基金会/美国心脏协会冠状动脉旁路移植术新指南：它们与2010年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南有何不同？
EuroIntervention. 2012 May 15;8(1):33-4. doi: 10.4244/EIJV8I1A6.
6
Essential messages from the ESC/EACTS guidelines on myocardial revascularization.欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南的重要信息。
Eur J Cardiothorac Surg. 2012 May;41(5):983-5. doi: 10.1093/ejcts/ezs023. Epub 2012 Feb 24.
7
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014 欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组。由欧洲经皮心血管介入协会（EAPCI）提供特别贡献制定。
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92. doi: 10.1093/ejcts/ezu366. Epub 2014 Aug 29.
8
ESC/EACTS guidelines on myocardial revascularization post-SYNTAX.欧洲心脏病学会/欧洲心胸外科学会关于SYNTAX评分后心肌血运重建的指南。
Eur J Cardiothorac Surg. 2014 Oct;46(4):511-3. doi: 10.1093/ejcts/ezu346. Epub 2014 Sep 4.
9
[ESC/EACTS guidelines on myocardial revascularization: the interventional cardiologist's point of view].[欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：介入心脏病学家的观点]
G Ital Cardiol (Rome). 2011 Apr;12(4):245-50.
10
[The new ESC/EACTS guidelines on myocardial revascularization: how ready are we to comply with?].[欧洲心脏病学会/欧洲心胸外科学会关于心肌血运重建的新指南：我们准备好遵循了吗？]
G Ital Cardiol (Rome). 2011 Apr;12(4):251-6.

引用本文的文献

1
Nationwide trends and outcomes of percutaneous coronary intervention for stable ischemic heart disease in end-stage kidney disease: a longitudinal study.终末期肾病患者稳定型缺血性心脏病经皮冠状动脉介入治疗的全国趋势和结果：一项纵向研究。
Ann Transl Med. 2024 Dec 24;12(6):111. doi: 10.21037/atm-24-85. Epub 2024 Dec 18.
2
Predictive value of combining urinary N-acetyl-β-D-glucosaminidase and serum homocysteine for contrast-induced nephropathy in patients after percutaneous coronary intervention.经皮冠状动脉介入治疗术后患者尿N-乙酰-β-D-氨基葡萄糖苷酶与血清同型半胱氨酸联合检测对造影剂肾病的预测价值
Front Cardiovasc Med. 2024 Aug 20;11:1423836. doi: 10.3389/fcvm.2024.1423836. eCollection 2024.
3
Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease-a meta-analysis.
药物涂层球囊：小血管冠状动脉疾病中支架策略的有效替代方案——一项荟萃分析
Front Cardiovasc Med. 2023 Aug 21;10:1213992. doi: 10.3389/fcvm.2023.1213992. eCollection 2023.
4
Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study.不同水化方法预防择期经皮冠状动脉介入治疗患者对比剂肾病的回顾性研究。
BMC Cardiovasc Disord. 2023 Jun 24;23(1):323. doi: 10.1186/s12872-023-03358-w.
5
High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry.高阿司匹林治疗血小板反应性与经皮冠状动脉介入治疗后再狭窄：冠状动脉内支架置入和抗栓治疗方案-阿司匹林和血小板抑制（ISAR-ASPI）登记研究结果。
Clin Res Cardiol. 2023 Sep;112(9):1231-1239. doi: 10.1007/s00392-023-02161-z. Epub 2023 Feb 14.
6
Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials.英格兰和威尔士选择性经皮冠状动脉介入治疗率： COURAGE 和 ORBITA 试验的影响。
J Am Heart Assoc. 2022 Sep 20;11(18):e025426. doi: 10.1161/JAHA.122.025426. Epub 2022 Sep 14.
7
Clinical Results of Drug-Coated Balloon Treatment in a Large-Scale Multicenter Korean Registry Study.韩国一项大规模多中心注册研究中药物涂层球囊治疗的临床结果
Korean Circ J. 2022 Jun;52(6):444-454. doi: 10.4070/kcj.2021.0261. Epub 2022 Mar 15.
8
A focused review on optimal coronary revascularisation in patients with chronic kidney disease: Coronary revascularisation in kidney disease.慢性肾脏病患者最佳冠状动脉血运重建的聚焦综述：肾脏病中的冠状动脉血运重建
AsiaIntervention. 2019 Feb;5(1):32-40. doi: 10.4244/AIJ-D-18-00015. Epub 2019 Feb 20.
9
NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的N末端B型利钠肽原与主要不良心血管事件：一项前瞻性队列研究。
Cardiol Res Pract. 2021 Nov 2;2021:9943668. doi: 10.1155/2021/9943668. eCollection 2021.
10
Comparison of multiple risk scores in assessing medium-to long-term clinical outcomes in unstable angina / non-ST-elevation myocardial infarction patients undergoing multi vessel percutaneous coronary intervention: An observational, registry-based study in India.比较多种风险评分在评估行经皮冠状动脉介入治疗多支血管不稳定型心绞痛/非 ST 段抬高型心肌梗死患者的中-长期临床结局中的作用：印度一项基于观察性登记研究。
Indian Heart J. 2021 Sep-Oct;73(5):555-560. doi: 10.1016/j.ihj.2021.08.001. Epub 2021 Aug 5.